Intelligence Platform
Patents
Browse 3,501 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9717742
Oxysterol analogue OXY133 induces osteogenesis and hedgehog signaling and inhibits adipoge
granted patentUS 9713628
Transplantation of neural cells
granted patentUS 9713607
Salinosporamides and methods of use thereof
granted patentUS 9713459
Method and system for in vivo hydrogen peroxide detection with ultrasound
granted patentUS 9714288
Antisense compounds and uses thereof
granted patentUS 9707284
Formulations of peptides and chloroquines for the treatment of pathogenic immune responses
granted patentUS 9708247
Modulators of the eIF2alpha pathway
granted patentUS 9701675
Activation of TRPV4 ion channel by physical stimuli and critical role for TRPV4 in organ-s
granted patentUS 9700519
Spray dry method for encapsulation of biological moieties and chemicals in polymers cross-
granted patentUS 9700596
Locally released growth factors to mediate motor recovery after stroke
granted patentUS 9700708
Maintaining multiple defined physiological zones using model predictive control
granted patentUS 9700620
Polymeric nanocarriers with light-triggered release mechanism
granted patentUS 9694074
Functionalized porous silicon nanoparticles and use thereof in photodynamic therapy
granted patentUS 9695249
Antibodies specific for urokinase-type plasminogen activator and methods of use thereof
granted patentUS 9695251
Activatable cell penetrating peptides with quenched fluorophores
granted patentUS 9694047
Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)
granted patentUS 9688673
Deoxycytidine kinase binding compounds
granted patentUS 9689042
Use of glycolytic pathways for inhibiting or measuring oncogenic signaling
granted patentUS 9687553
Polymeric nanocarriers with linear dual response mechanism
granted patentUS 9682106
Method for combined conditioning and chemoselection in a single cycle
granted patentUS 9683009
Bone-selective osteogenic oxysterol-bone targeting agents
granted patentUS 9682151
Peptides whose uptake in cells is controllable
granted patentUS 9678060
Lunasin-induced regulation of disease-related gene expression
granted patentUS 9675649
Disialyllacto-N-tetraose (DSLNT) or variants, isomers, analogs and derivatives thereof to
granted